Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.
Journal of Surgical Oncology|September 17, 2013
Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 studyMarianne Sinn, Jana K Striefler, Bruno V Sinn, et al.
Histopathology|June 16, 2010
Expression of classical NF-kappaB pathway effectors in human ovarian carcinomaSilvia Darb-Esfahani, Bruno V Sinn, Wilko Weichert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Sven Bischoff, et al.
BMC Cancer|February 5, 2021
Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samplesChunxiao Fu, Michal Marczyk, Michael Samuels, et al.
Virchows Archiv : an International Journal of Pathology|November 14, 2009
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissueBruno V Sinn, Silvia Darb-Esfahani, Ralph M Wirtz, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Endocrine-Related Cancer|August 14, 2009
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissueSilvia Darb-Esfahani, Ralph M Wirtz, Bruno V Sinn, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 TrialMarianne Sinn, Bruno V Sinn, Denise Treue, et al.
Pageof 5